Elevated CCL2 and/or CCR2 mRNA expression trends toward adverse prognosis. Comparative analysis of progression-free survival (PFS) and overall survival (OS) based on the mRNA expression levels of MYC or/and BCL2 using publicly available data sets. (A-F) Schmitz et al,¹⁸ (G-H) GSE117556, and (I) GSE181063. Survival analysis was performed using the Kaplan-Meier method and log-rank test.